Chandan Basho - May 16, 2024 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Role: COO and CFO
Signature: /s/ Chandan Basho
Stock symbol: ASTH
Transactions as of: May 16, 2024
Transactions value $: -$290,008
Form type: 4
Date filed: 5/17/2024, 04:16 PM
Previous filing: Apr 4, 2024
Next filing: Nov 12, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ASTH	Common Stock	Tax liability	-$290K	-7.05K	-4.45%	$41.13	151K	May 16, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock.
F2	Includes 64,594 shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 14,427 shares, which vest in two equal annual installments on April 14, 2025 and 2026; (ii) 4,561 shares, which vest on May 16, 2025; and (iii) 45,606 shares, which vest in three equal annual installments on May 16, 2025, 2026 and 2027. Also includes 15,692 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 2, 2024 (subject to continuous employment with the Issuer).

Content

Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock.

Includes 64,594 shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 14,427 shares, which vest in two equal annual installments on April 14, 2025 and 2026; (ii) 4,561 shares, which vest on May 16, 2025; and (iii) 45,606 shares, which vest in three equal annual installments on May 16, 2025, 2026 and 2027. Also includes 15,692 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 2, 2024 (subject to continuous employment with the Issuer).